2017
DOI: 10.1007/s00467-017-3766-5
|View full text |Cite
|
Sign up to set email alerts
|

The FGF23–Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease—a prospective cohort study

Abstract: BackgroundChronic kidney disease-associated mineral bone disorder (CKD-MBD) is common in pediatric kidney disease patients and a risk factor for future cardiovascular disease (CVD). Fibroblast growth factor-23 (FGF23) and Klotho are novel key players in CKD-MBD, and has been suggested to be involved in the development of CVD.MethodsThis prospective cohort study included 74 pediatric patients; 31 with CKD (age range 0.8–18.8 years, glomerular filtration rate (GFR) range 9–68 mL/min/1.73 m2) and 43 transplanted … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
16
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 50 publications
2
16
0
Order By: Relevance
“…There is good evidence from clinical and experimental studies that both acute and chronic renal failure are associated with reduced expression of Klotho in the kidney, and with reduced sKlotho levels in the blood [ 43 ▪▪ , 44 47 ]. In agreement with these data, kidney transplantation in CKD patients results in a rapid rise in circulating sKlotho, and a decline in circulating FGF23 levels [ 48 ▪ , 49 ▪ ]. Conversely, treatment of mice with sKlotho improves outcome in acute and chronic renal injury models [ 50 ▪▪ ].…”
Section: Pathophysiological Role Of Klotho In Acute and Chronic Renalsupporting
confidence: 53%
“…There is good evidence from clinical and experimental studies that both acute and chronic renal failure are associated with reduced expression of Klotho in the kidney, and with reduced sKlotho levels in the blood [ 43 ▪▪ , 44 47 ]. In agreement with these data, kidney transplantation in CKD patients results in a rapid rise in circulating sKlotho, and a decline in circulating FGF23 levels [ 48 ▪ , 49 ▪ ]. Conversely, treatment of mice with sKlotho improves outcome in acute and chronic renal injury models [ 50 ▪▪ ].…”
Section: Pathophysiological Role Of Klotho In Acute and Chronic Renalsupporting
confidence: 53%
“…In those patients, high FGF23 and low Klotho levels were strongly associated with impaired left ventricular diastolic function [67]. In addition to this finding, FGF23 signaling via fibroblast growth factor receptor 4 (FGFR4) activates the phospholipase Cγ/calcineurin/nuclear factor of the activated T-cell pathway, and thus promotes cardiac myocyte hypertrophy, independent of its co-receptor Klotho [60,67]. Furthermore, FGFR4 signaling is responsible for FGF23-mediated increased cardiac contractility [68].…”
Section: Klothomentioning
confidence: 98%
“…In pediatric CKD patients, serum FGF23 levels increased and Klotho levels decreased with progressing renal failure, while phosphorus levels were maintained in the normal range [67]. In those patients, high FGF23 and low Klotho levels were strongly associated with impaired left ventricular diastolic function [67]. In addition to this finding, FGF23 signaling via fibroblast growth factor receptor 4 (FGFR4) activates the phospholipase Cγ/calcineurin/nuclear factor of the activated T-cell pathway, and thus promotes cardiac myocyte hypertrophy, independent of its co-receptor Klotho [60,67].…”
Section: Klothomentioning
confidence: 98%
See 1 more Smart Citation
“…A two-dimensional guided M-mode measurement and conventional pulse wave Doppler were performed according to the American Society of Echocardiography guidelines [14]. Left atrial diameter, left ventricular end-diastolic volume (LVEDD), left ventricular posterior wall thickness (PWT), interventricular septal thickness (IVST), and LVEF were determined.…”
Section: Methodsmentioning
confidence: 99%